Presentation Information
[S38-4]Mutation-independent targeted gene insertion therapeutics to treat autosomal dominant retinitis pigmentosa in mouse and primate systems
○Akishi Onishi1,2,3,4 (1. VCGT Inc., 2. Res. Org. Sci. Tech., Ritsumeikan Univ., 3. RIKEN BZP, 4. Kobe City Eye Hospital Research Center)